Drug intelligence / Profile preview

bael pulp powder

Development stage
Unknown
Modality
Small Molecules
Administration
Oral (as Powder Mixed With Water/milk/yogurt), Topical (occasionally Applied To Skin Ulcers/rashes)
01

Overview

Bael pulp powder is a powdered preparation made from the dried pulp of the fruit of *Aegle marmelos*, commonly known as bael or bilva. It is widely used in traditional Ayurvedic medicine and folk remedies across India and Southeast Asia. The main bioactive constituents include tannins, flavonoids, coumarins, alkaloids (such as aegeline), phenolic compounds, vitamins (notably vitamin C), minerals (potassium, calcium), and dietary fiber[1][4][8]. Bael pulp powder is traditionally used for digestive health—especially to manage diarrhea and constipation—due to its antimicrobial activity against gut pathogens and its high fiber content which acts as a mild laxative[3][8]. Other purported uses include blood sugar regulation in diabetes (possibly by enhancing insulin secretion or reducing glucose absorption), cholesterol management via antioxidant effects on lipid profiles[2][3], anti-inflammatory action for skin conditions and ulcers[7], immune support due to antioxidant content[6], respiratory health through bronchodilatory effects of β-caryophyllene[8], liver detoxification, lactation support by increasing prolactin levels[2][6], wound healing, and general nutritional supplementation. However, robust clinical evidence supporting these uses remains limited; most data are from traditional use or preclinical studies.

Other names
baelbilvaAegle marmelosbael fruit powder
02

Targets

CYP3A4 (Cytochrome P450 3A4)CYP2C9 (Cytochrome P450 family 2 subfamily C member 9)CYP2D6 (Cytochrome P450 2D6)CYP1A2 (Cytochrome P450 1A2)

Beyond the preview

Go deeper on bael pulp powder.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bael pulp powder.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call